Arrowstreet Capital’s iKang Healthcare Group, Inc. KANG Stock Holding History

Arrowstreet Capital’s Portfolio KANG Stock Details KANG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-51,363	Closed	-$930K	–	1598
2018 Q3	$930K	Buy	+51,363	New	+$989K	﹤0.01%	813
2016 Q1	–	Sell	-95,875	Closed	-$1.96M	–	1665
2015 Q4	$1.96M	Buy	+95,875	New	+$1.65M	0.01%	809

Other funds holding KANG

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CFIC

City Financial Investment Company London, United Kingdom $562M AUM 5.93% 1-Year Est. Return

Conning Inc Hartford, Connecticut $3.01B AUM 16.23% 1-Year Est. Return

Arrowstreet Capital's KANG Position: Q4 2018 in Review

Arrowstreet Capital sold out of iKang Healthcare Group, Inc. (KANG) in Q4 2018, closing a stake of 51,363 shares — an estimated $930K sold.

Arrowstreet Capital first reported a position in KANG in Q4 2015 and held it in 2 quarters. The position peaked at $1.96M in Q4 2015. 54 funds tracked by Wall St. Rank hold KANG as of Q4 2018.

Arrowstreet Capital reported no remaining iKang Healthcare Group, Inc. position as of Q4 2018 after selling out during the quarter.
Arrowstreet Capital sold 51,363 iKang Healthcare Group, Inc. shares in Q4 2018, an estimated $930K.
Arrowstreet Capital first reported a position in iKang Healthcare Group, Inc. in Q4 2015 and held it in 2 quarters.
Arrowstreet Capital's iKang Healthcare Group, Inc. position peaked at $1.96M in Q4 2015.
54 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q4 2018.

Based on Arrowstreet Capital's 13F filing for Q4 2018, filed 14 Feb 2019.